Novel androstane-17.beta.-carboxylic acid esters, a process and

Details Novel androstane-17.beta.-carboxylic acid esters, a process and Novel androstane-17.beta.-carboxylic acid esters, a process and

1987-01-05

1989-04-11

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

540 70, A61K 3158, C07J 7100

Patent

active

048207004

ABSTRACT:
The invention refers to compounds having anti-inflammatory activity, characterized by the formula ##STR1## in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents in the carbon atom at position 20, in which formula the 1,2 position is saturated or is a double bond,

REFERENCES:
patent: 4119625 (1978-10-01), Schmidlin
patent: 4198336 (1980-04-01), Alvarez
patent: 4198403 (1980-04-01), Alvarez
R. Brattsand, A. Thalen, K. Roempke, L. Kallstrom, E. Gruvstad--Influence of 16.alpha.,17.alpha.-Acetal Substitution and Steroid Nucleus Fluorination on the Topical to Systemic Activity Ratio of Glucocorticoids-1982.
R. Brattsand, A. Thalen, K. Roempke, L. Kallstrom, E. Gruvstad--Development of New Glucocorticosteroids with a Very High Ratio Between Topical; and Systemic Activities-1982.

Affiliated with

Also associated with

Rating

Novel androstane-17.beta.-carboxylic acid esters, a process and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel androstane-17.beta.-carboxylic acid esters, a process and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel androstane-17.beta.-carboxylic acid esters, a process and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-667380